Any Guess which Module might be Next up...
Sounds Lucrative.
Antimicrobial susceptibility testing (AST) has gained widespread popularity worldwide in accelerating initiation of the targeted antimicrobial therapy used for patients affected from infections. Although new and rapid antimicrobial susceptibility testing technologies, such as genomic approaches, digital imaging, and phenotyping methods, have been studied in the recent past, there hasn’t been a single breakthrough in the development of rapid AST platform.
This is mainly because of barriers that prevent timely development & implementation of rapid antimicrobial susceptibility testing platform. Industry experts across the globe have been focusing on utility of new approaches, uptake of novel tools, target product profile optimization, and validation of new technologies against the reference methods that extend beyond proof-of-concept phases.
North America and Europe is expected to remain a lucrative region for growth of the antimicrobial susceptibility testing market. Growing awareness about treatment options available, and continuous research efforts toward development of new advanced drugs, are some of the key factors underpinning demand for antimicrobial susceptibility testing in these regions.
Asia-Pacific is also expected to hold potential for growth of the antimicrobial susceptibility testing market, driven by increasing number of infection-related cases in the region.
- Forums
- ASX - By Stock
- LBT
- Technicals - Good breakout on increasing volume - early days
Technicals - Good breakout on increasing volume - early days, page-140
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LBT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $26.23M |
Open | High | Low | Value | Volume |
1.6¢ | 1.6¢ | 1.5¢ | $25.37K | 1.614M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1889697 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 506743 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1889697 | 0.015 |
6 | 1381428 | 0.014 |
1 | 600000 | 0.013 |
2 | 6718666 | 0.012 |
2 | 78500 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 506743 | 1 |
0.017 | 727416 | 2 |
0.018 | 1604121 | 9 |
0.019 | 1316951 | 8 |
0.020 | 1018882 | 2 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
LBT (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online